Literature DB >> 2285630

The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs.

G J Grover1, S Dzwonczyk, C S Parham, P G Sleph.   

Abstract

The direct myocardial protective effects of intracoronary infusions of cromakalim and pinacidil were determined in an anesthetized canine model of coronary occlusion and reperfusion. The left circumflex coronary artery was occluded for 90 minutes and reperfused for 5 hours, at which time the infarct size was determined. Cromakalim (0.1 micrograms/kg/min) or pinacidil (0.09 micrograms/kg/min) were infused into the left circumflex coronary artery starting 10 minutes preischemia. Cromakalim significantly reduced infarct size as a percent of the left ventricular area at risk (25 +/- 5%) compared with vehicle controls (55 +/- 7%). Pinacidil did not reduce infarct size at an equimolar dose, but at the higher dose also significantly reduced infarct size. Collateral blood flow was not significantly altered by either drug, though reperfusion flow was significantly higher in cromakalim-treated animals, particularly in the subepicardial region. When the same dose of cromakalim was given starting 2 minutes before the initiation of reperfusion, no significant beneficial effect of cromakalim was observed. In another study, isolated buffer-perfused rat hearts were subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. These hearts were treated with 7 microM cromakalim, either starting 10 minutes before ischemia or only during reperfusion, and its effect on reperfusion function and LDH release were determined. Cromakalim pretreatment (both when given throughout the experiment and when not present in the reperfusion buffer) resulted in significant improvements in the reperfusion function. Reperfusion contracture and LDH were also significantly reduced with this treatment. When given only during reperfusion, cromakalim did not reduce the severity of ischemia when compared with vehicle controls. Thus, both cromakalim and pinacidil reduce ischemic/reperfusion injury, though the timing of treatment may be important.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285630     DOI: 10.1007/bf01857755

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  31 in total

1.  Modification of K+ conductance of heart cell membrane by BRL 34915.

Authors:  W Osterrieder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

2.  Effect of intracoronary diltiazem on ST-segment elevation and myocardial blood flow during pacing-induced ischemia.

Authors:  G J Grover; C S Parham
Journal:  J Cardiovasc Pharmacol       Date:  1987-11       Impact factor: 3.105

3.  Relative error and variability in blood flow measurements with radiolabeled microspheres.

Authors:  W P Dole; D L Jackson; J I Rosenblatt; W L Thompson
Journal:  Am J Physiol       Date:  1982-09

4.  Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment.

Authors:  H M Lo; R A Kloner; E Braunwald
Journal:  Am J Cardiol       Date:  1985-10-01       Impact factor: 2.778

5.  Mechanism of protection by verapamil and nifedipine from anoxic injury in isolated cardiac myocytes.

Authors:  J Y Cheung; A Leaf; J V Bonventre
Journal:  Am J Physiol       Date:  1984-03

6.  Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine.

Authors:  J L Hill; L S Gettes
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

7.  Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels.

Authors:  M Fosset; J R De Weille; R D Green; H Schmid-Antomarchi; M Lazdunski
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

8.  Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.

Authors:  N S Cook; U Quast; R P Hof; Y Baumlin; C Pally
Journal:  J Cardiovasc Pharmacol       Date:  1988-01       Impact factor: 3.105

9.  Protective effect of nicorandil on postischemic function and tissue adenine nucleotides following a brief period of low-flow global ischemia in the isolated perfused rat heart.

Authors:  G M Pieper; G J Gross
Journal:  Pharmacology       Date:  1989       Impact factor: 2.547

10.  Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.

Authors:  D Angerbach; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

View more
  16 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 3.  K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.

Authors:  D Kent Arrell; Jelena Zlatkovic Lindor; Satsuki Yamada; Andre Terzic
Journal:  Cardiovasc Res       Date:  2011-02-14       Impact factor: 10.787

4.  Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

5.  Postrevascularization recovery of fatty acid utilization in ischemic myocardium: a randomized clinical trial of potassium channel opener.

Authors:  Y Kuwabara; S Watanabe; J Nakaya; R Hasegawa; K Matsuno; T Kuroda; Y Mikami; K Fujii; A Miyazaki; T Saito; Y Masuda
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

6.  Cardioprotection associated with preconditioning in the anesthetized ferret.

Authors:  A W Gomoll
Journal:  Basic Res Cardiol       Date:  1996 Nov-Dec       Impact factor: 17.165

7.  Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts.

Authors:  P Wang; J M Downey; M V Cohen
Journal:  Basic Res Cardiol       Date:  1996 Nov-Dec       Impact factor: 17.165

8.  Involvement of ATP-sensitive potassium channels in preconditioning protection.

Authors:  S Rohmann; H Weygandt; P Schelling; L Kie Soei; P D Verdouw; I Lues
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

9.  Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.

Authors:  E J Hide; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.

Authors:  E J Hide; P Ney; J Piper; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.